2021
DOI: 10.1155/2021/6618061
|View full text |Cite
|
Sign up to set email alerts
|

Mas Receptor Blockade Promotes Renal Vascular Response to Ang II after Partial Kidney Ischemia/Reperfusion in a Two-Kidney-One-Clip Hypertensive Rats Model

Abstract: Background. Partial kidney ischemia-reperfusion (IR) injury is the principal cause of acute kidney injury. The renin-angiotensin system (RAS) and hypertension also may be influenced by renal IR injury. In two models of partial renal IR with and without ischemia preconditioning (IPC) and using Mas receptor (MasR) blockade, A779 or its vehicle, the renal vascular responses to angiotensin II (Ang II) administration in two-kidney-one-clip (2K1C) hypertensive rats were determined. Methods. Thirty-seven 2K1C male Wi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 50 publications
0
2
0
Order By: Relevance
“…AVE0991 treatment in the renal I/R model in male C57BL/6 Wild-type or Mas−/− mice promoted renoprotective effects and decreased infiltration of leuko­cytes in the kidney [60]. Karimi and Nematbakhsh reported that in 2K1C rats, after partial I/R, MasR has an essential role during Ang II infusion [100] because, after A779 administration, RBF response to Ang II infusion increased in males rats. In another study, after a moderate renal I/R, A779 alone or A779 + PD123319 (AT2R antagonist) infusion increased the RBF and RVR responses to Ang II infusion significantly in females but not in the male rats [101], so that simultaneous AT2R and MasR blockade decreased renal vasoconstriction following Ang II infusion.…”
Section: Mas Receptormentioning
confidence: 99%
“…AVE0991 treatment in the renal I/R model in male C57BL/6 Wild-type or Mas−/− mice promoted renoprotective effects and decreased infiltration of leuko­cytes in the kidney [60]. Karimi and Nematbakhsh reported that in 2K1C rats, after partial I/R, MasR has an essential role during Ang II infusion [100] because, after A779 administration, RBF response to Ang II infusion increased in males rats. In another study, after a moderate renal I/R, A779 alone or A779 + PD123319 (AT2R antagonist) infusion increased the RBF and RVR responses to Ang II infusion significantly in females but not in the male rats [101], so that simultaneous AT2R and MasR blockade decreased renal vasoconstriction following Ang II infusion.…”
Section: Mas Receptormentioning
confidence: 99%
“…Renal ischemia-reperfusion injury (RIRI) is a sequence of complicated events that is defined as a reduction of the blood supply followed by the recovery of perfusion and reoxygenation to the kidney [ 1 ]. The most clinical conditions of RIRI include sepsis, renal transplantation, kidney surgery, blood volume depletion, and septic shock [ 2 , 3 ].…”
Section: Introductionmentioning
confidence: 99%